SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,558 | -86.5% | 899,773 | -12.3% | 0.00% | -100.0% |
| Q2 2023 | $1,226,056 | +22.9% | 1,025,988 | -28.9% | 0.00% | +50.0% |
| Q1 2023 | $997,719 | +19.2% | 1,443,459 | +17.1% | 0.00% | 0.0% |
| Q4 2022 | $836,842 | -53.8% | 1,232,463 | -30.0% | 0.00% | -60.0% |
| Q3 2022 | $1,813,000 | +3.4% | 1,760,614 | -31.7% | 0.01% | +25.0% |
| Q2 2022 | $1,754,000 | -45.9% | 2,578,143 | -33.4% | 0.00% | +33.3% |
| Q1 2022 | $3,242,000 | +40.3% | 3,869,128 | +173.0% | 0.00% | -40.0% |
| Q4 2021 | $2,310,000 | -34.3% | 1,417,041 | -2.9% | 0.01% | -44.4% |
| Q3 2021 | $3,518,000 | -9.3% | 1,459,894 | -0.6% | 0.01% | -18.2% |
| Q2 2021 | $3,878,000 | -58.9% | 1,468,770 | -22.3% | 0.01% | -66.7% |
| Q1 2021 | $9,433,000 | – | 1,890,402 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |